RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aspira Pathlab & Diagnostics - Stock

Aspira Pathlab & Diagnostics ROA 2024

Aspira Pathlab & Diagnostics ROA

-0.18

Ticker

540788.BO

ISIN

INE500C01017

In 2024, Aspira Pathlab & Diagnostics's return on assets (ROA) was -0.18, a -173.88% increase from the 0.25 ROA in the previous year.

Aspira Pathlab & Diagnostics Aktienanalyse

What does Aspira Pathlab & Diagnostics do?

Aspira Pathlab & Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Aspira Pathlab & Diagnostics's Return on Assets (ROA)

Aspira Pathlab & Diagnostics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Aspira Pathlab & Diagnostics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Aspira Pathlab & Diagnostics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Aspira Pathlab & Diagnostics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Aspira Pathlab & Diagnostics Stock

What is the Return on Assets (ROA) of Aspira Pathlab & Diagnostics this year?

The Return on Assets (ROA) of Aspira Pathlab & Diagnostics is -0.18 undefined this year.

What was the ROA of Aspira Pathlab & Diagnostics compared to the previous year?

The ROA of Aspira Pathlab & Diagnostics has increased by -173.88% compared to the previous year.

What consequences do high ROA have for investors of Aspira Pathlab & Diagnostics?

A high ROA is advantageous for investors of Aspira Pathlab & Diagnostics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Aspira Pathlab & Diagnostics?

A low ROA can be unfavorable for investors of Aspira Pathlab & Diagnostics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Aspira Pathlab & Diagnostics affect the company?

An increase in ROA of Aspira Pathlab & Diagnostics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Aspira Pathlab & Diagnostics impact the company?

A reduction in the ROA of Aspira Pathlab & Diagnostics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Aspira Pathlab & Diagnostics?

Some factors that can influence the ROA of Aspira Pathlab & Diagnostics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Aspira Pathlab & Diagnostics important for investors?

The ROA of Aspira Pathlab & Diagnostics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Aspira Pathlab & Diagnostics take to improve ROA?

To improve ROA, Aspira Pathlab & Diagnostics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Aspira Pathlab & Diagnostics pay?

Over the past 12 months, Aspira Pathlab & Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aspira Pathlab & Diagnostics is expected to pay a dividend of 0 INR.

What is the dividend yield of Aspira Pathlab & Diagnostics?

The current dividend yield of Aspira Pathlab & Diagnostics is .

When does Aspira Pathlab & Diagnostics pay dividends?

Aspira Pathlab & Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aspira Pathlab & Diagnostics?

Aspira Pathlab & Diagnostics paid dividends every year for the past 0 years.

What is the dividend of Aspira Pathlab & Diagnostics?

For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aspira Pathlab & Diagnostics located?

Aspira Pathlab & Diagnostics is assigned to the '-' sector.

Wann musste ich die Aktien von Aspira Pathlab & Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aspira Pathlab & Diagnostics from 6/21/2024 amounting to 0 INR, you needed to have the stock in your portfolio before the ex-date on 6/21/2024.

When did Aspira Pathlab & Diagnostics pay the last dividend?

The last dividend was paid out on 6/21/2024.

What was the dividend of Aspira Pathlab & Diagnostics in the year 2023?

In the year 2023, Aspira Pathlab & Diagnostics distributed 0 INR as dividends.

In which currency does Aspira Pathlab & Diagnostics pay out the dividend?

The dividends of Aspira Pathlab & Diagnostics are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aspira Pathlab & Diagnostics

Our stock analysis for Aspira Pathlab & Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aspira Pathlab & Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.